ShangPharma starts $60M expansion in Qidong

ShangPharma Corp. (Shanghai, China) said it will expand its operations and build a research and manufacturing facility in the Qidong Biopharma Industrial Zone in Qidong, China. ShangPharma and the Industrial Zone will invest $60 million in the new infrastructure.

ShangPharma said its CRO division, ChemPartner, would operate the new research facility and its contract manufacturing division, China Gateway Biologics, would operate the manufacturing facility. ...